Literature DB >> 16572402

Trilateral retinoblastoma.

Célia B G Antoneli1, Karina de Cássia B Ribeiro, Luis Henrique Sakamoto, Martha M Chojniak, Paulo Eduardo R S Novaes, Victor E A Arias.   

Abstract

BACKGROUND: Trilateral retinoblastoma (TRB) is a syndrome consisting of unilateral or bilateral hereditary retinoblastoma (Rb) associated with an intracranial neuroblastic tumor. Although its incidence is low, the prognosis is very poor. This article reports four cases of TRB and discusses the role of neuroimaging screening for early detection. PROCEDURE: From January 1986 to December 2003, 470 children with Rb were admitted to the Pediatrics and Ophthalmology Departments, A C Camargo Hospital, São Paulo, Brazil.
RESULTS: There were four patients with pineoblastoma, two of whom had a positive familial history. The age at diagnosis of Rb was 4, 6, 10, and 24 months while the age of diagnosis of TRB was 10, 25, 57, and 72 months. One patient presented TRB at initial diagnosis of Rb. Three patients had bilateral disease and all of them had one eye enucleated, followed by chemotherapy and/or external beam radiation therapy (EBRT). One child with unilateral disease was only submitted to enucleation. In spite of intensive treatment, all patients died with progressive disease within 7, 8, 12, and 12 months after diagnosis of TRB.
CONCLUSIONS: Early diagnosis as well as new therapeutic approaches are needed to achieve better results. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16572402     DOI: 10.1002/pbc.20793

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

1.  Trilateral retinoblastoma: A systematic review of 211 cases.

Authors:  Ryuya Yamanaka; Azusa Hayano; Yasuo Takashima
Journal:  Neurosurg Rev       Date:  2017-08-16       Impact factor: 3.042

2.  Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.

Authors:  Martin Mynarek; Barry Pizer; Christelle Dufour; Dannis van Vuurden; Miklos Garami; Maura Massimino; Jason Fangusaro; Tom Davidson; Maria Joao Gil-da-Costa; Jaroslav Sterba; Martin Benesch; Nicolas Gerber; B Ole Juhnke; Robert Kwiecien; Torsten Pietsch; Marcel Kool; Steve Clifford; David W Ellison; Felice Giangaspero; Pieter Wesseling; Floyd Gilles; Nicholas Gottardo; Jonathan L Finlay; Stefan Rutkowski; Katja von Hoff
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

3.  Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission.

Authors:  Firazia Rodjan; Pim de Graaf; Hervé J Brisse; Sophia Göricke; Philippe Maeder; Paolo Galluzzi; Isabelle Aerts; Claire Alapetite; Laurence Desjardins; Regina Wieland; Maja Beck Popovic; Manuel Diezi; Francis L Munier; Theodora Hadjistilianou; Dirk L Knol; Annette C Moll; Jonas A Castelijns
Journal:  J Neurooncol       Date:  2012-07-18       Impact factor: 4.130

4.  Retinoblastoma in a pediatric oncology reference center in Southern Brazil.

Authors:  Simone G A Selistre; Marcelo K Maestri; Patricia Santos-Silva; Lavinia Schüler-Faccini; Luis S P Guimarães; Juliana Giacomazzi; Mario C Evangelista Júnior; Patricia Ashton-Prolla
Journal:  BMC Pediatr       Date:  2016-04-03       Impact factor: 2.125

5.  Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success.

Authors:  Marcel Opitz; Denise Bos; Cornelius Deuschl; Alexander Radbruch; Sebastian Zensen; Selma Sirin; Michael Forsting; Nikolaos Bechrakis; Eva Biewald; Norbert Bornfeld; Petra Ketteler; Beate Timmermann; Martin Stuschke; Maja Guberina; Axel Wetter; Sophia Göricke; Nika Guberina
Journal:  Neuroradiology       Date:  2020-08-29       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.